CXCR4 and cancer: Due to the heterogeneous accumulation of the CXCR4-targeted tracer and the small patient population, the [68Ga]Pentixafor study failed to clearly demonstrate its usefulness for cancer prediction, prognosis, or tumor grade of breast cancer.